A team of scientists have identified two genes that can regulate levels of healthy fats, called FAHFAs, in mice. They found that the loss of the two genes led to higher-than-normal levels of the beneficial FAHFAs, while blocking the genes’ activity with an experimental drug also increased FAHFA levels. Because FAHFAs decrease inflammation and increase insulin sensitivity, a better understanding of the activity of their regulatory genes may eventually lead to therapies for people with diabetes and inflammation.
- Scientists publish a blueprint to apply artificial intelligence to extend human longevity
- Detecting ADHD with near perfect accuracy
- Hypnotic suggestions can make a complex task easy by helping vision fill in the blanks
- In Brazil, many smaller dams disrupt fish more than large hydropower projects
- Is there a link between cashless payments and unhealthy consumption?